Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB26FV2Z9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,643
Award facts
- Contract value 100% obligated
- $11,643.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,643.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. This delivery order, issued on November 12, 2025, with an ultimate completion date of December 4, 2025, operates under a firm fixed-price contract structure with no set-aside designation. The award leverages DMS Pharmaceutical Group's established position as a critical pharmaceutical supplier within the federal military medical supply chain, demonstrating the company's competitive capability in unrestricted government procurement.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy that encompasses multiple regional prime vendor contractors. The underlying IDC, awarded on November 13, 2025, carries a $499.999 billion ceiling value and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. This contract structure positions DMS Pharmaceutical Group as a key supplier of branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to support Department of Defense healthcare operations globally, with delivery orders such as this one enabling rapid fulfillment of recurring pharmaceutical needs across military medical facilities worldwide.
Quick answers
Who was awarded contract SPE2DB26FV2Z9?
SPE2DB26FV2Z9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DB26FV2Z9 worth?
The government has obligated $11,643 on SPE2DB26FV2Z9.
Is contract SPE2DB26FV2Z9 an order under another contract?
Yes. SPE2DB26FV2Z9 is a delivery order under SPE2DB20D9332, an indefinite delivery contract.
Was contract SPE2DB26FV2Z9 competed?
The extent of competition for SPE2DB26FV2Z9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award